The ACP issued new clinical guidance on preventing episodic migraines, classified as one to 14 headache days per month, in ...

With historical data showing migraine to be underdiagnosed and undertreated, new guidance from the American College of ...

The American College of Physicians (ACP) has developed new recommendations to prevent episodic migraines in nonpregnant ...

The Clinical Guidelines Committee of the American College of Physicians (ACP) has released a new clinical guideline on the ...

The Food and Drug Administration (FDA) has approved Symbravo ® (meloxicam/rizatriptan) for the acute treatment of migraine with or without aura in adults.

FDA approves Symbravo for acute migraine relief, combining rizatriptan and meloxicam. Discover its unique benefits and fast absorption for effective symptom control.

In this systematic review, patients with episodic migraine preferred oral pharmacologic treatments that reduced the severity, ...

Migraines affect millions worldwide, yet remain widely misunderstood. This neurological condition extends far beyond typical headache symptoms, often ...

For Roshelle, her diagnosis of migraine disease became the catalyst for a life of advocacy, empowerment, and community ...

Vestibular migraines are more likely to affect ... t a medication specifically for treating vestibular migraine. Your treatment may include medications to prevent attacks or stop symptoms once ...

A CORONER has raised concerns that chiropractors aren’t required to check patient medical records after a woman’s death.

The American College of Physicians (ACP) has developed new recommendations to prevent episodic migraines in nonpregnant adults in outpatient settings.